- /
- Supported exchanges /
- OTCGREY /
- CSSPF.OTCGREY
Circassia Group Plc (CSSPF OTCGREY) stock market data APIs
Circassia Group Plc Financial Data Overview
NIOX Group Plc engages in the design, development, and commercialization of medical devices for the measurement of fractional exhaled nitric oxide (FeNo) worldwide. Its products include NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of FeNo level in patients. The company was formerly known as Circassia Group Plc and changed its name to NIOX Group Plc in September 2022. NIOX Group Plc was incorporated in 2006 and is headquartered in Oxford, the United Kingdom.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Circassia Group Plc data using free add-ons & libraries
Get Circassia Group Plc Fundamental Data
Circassia Group Plc Fundamental data includes:
- Net Revenue: 39 000 K
- EBITDA: 9 500 K
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2021-06-30
- EPS/Forecast: 0
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Circassia Group Plc News
Calculating The Intrinsic Value Of NIOX Group Plc (LON:NIOX)
Key Insights NIOX Group's estimated fair value is UK£0.81 based on 2 Stage Free Cash Flow to Equity With UK£0.70 share price, NIOX Group appears to be trading close to its estimated fair value Indu...
With 52% ownership of the shares, NIOX Group Plc (LON:NIOX) is heavily dominated by institutional owners
Key Insights Institutions' substantial holdings in NIOX Group implies that they have significant influence over the company's share price The top 3 shareholders own 54% of the company Insiders have s...
Lacklustre Performance Is Driving NIOX Group Plc's (LON:NIOX) Low P/S
You may think that with a price-to-sales (or "P/S") ratio of 7.2x NIOX Group Plc (LON:NIOX) is definitely a stock worth checking out, seeing as almost half of all the Biotechs companies in the United ...
If EPS Growth Is Important To You, NIOX Group (LON:NIOX) Presents An Opportunity
Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks' without any revenue, let alone profit. Sometimes these stories can cloud the minds ...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.